An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics

NCT01060124 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain; Cancer

Interventions

DRUG: Fentanyl D-trans

Sponsor

Janssen Korea, Ltd., Korea